Exodus Point Capital Management, LP Aptinyx Inc. Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.21 - $2.89 $80,293 - $104,999	-36,332 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.39 - $3.5 $40,474 - $59,272	16,935 Added 87.31%	36,332 $103,000
Q1 2021 May 17, 2021	BUY	$2.86 - $4.33 $55,475 - $83,989	19,397 New	19,397 $58,000
Q2 2020 Aug 14, 2020	SELL	$1.99 - $4.4 $22,089 - $48,840	-11,100 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.81 - $5.03 $26,073 - $72,457	-14,405 Reduced 56.48%	11,100 $24,000
Q4 2019 Feb 14, 2020	BUY	$2.84 - $4.25 $72,434 - $108,396	25,505 New	25,505 $87,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.